Nutrition and Cancer · 2012 · 33 citations · 36 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyMolecular OncologyAngiogenesisAngiogenesis In CancerOncology PharmacologyAngiogenesis In NeoplasmsAnticancer ActivityAnticancer Natural ProductsAntiproliferative AgentsAntiproliferative Drug ActionTumor Angiogenesis ModelsVascular Endothelial Growth FactorVascular Endothelial Growth Factor Inhibition
Curcumin has long been used as an antioxidative, antiinflammatory, and modulator of pathological angiogenesis, whereas naringenin is a well-known immunomodulator. In this report, we investigated the effect of curcumin and naringenin on the growth of Ehrlich ascites carcinoma tumor model. To achieve this, Swiss albino mice were implanted intraperitoneally with 1 × 10⁶ Ehrlich ascites carcinoma cells followed by the administration of oral doses of naringenin and curcumin either individually (50 mg/kg body weight) or in combination (20 mg/kg body weight each). A marked reduction has been seen in the total number of cells (80%) and accumulation of ascetic fluid (55%) when these drugs were administered together. These drugs proved to be an effective angio-inhibitory compound and confirmed by different in vivo assay systems, viz. peritoneal/skin angiogenesis and chorioallantoic membrane assay. Antiangiogenic and antiproliferative effect of these compounds alone or in combination was further corroborated with immunoblot results where we confirmed the downregulation of vascular endothelial growth factor, Hif1α, heat shock protein 90, and p-Akt. Furthermore, treatment with naringenin and curcumin alone or in combination substantially improved hepatocellular architecture and no noticeable neoplastic lesions or cellular alteration were reported. These outcomes put forward a plausible clinical application of these diet-derived compounds, as both angioinhibitory and antitumor in association with conventional therapy.
36
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Donald R. Senger, Stephen J. Galli, Ann M. Dvořàk et al. · Science · 1983 · 4K citations
Medicine, Biochemistry, Oncology +13
Transplacental Carcinogenesis by Stilbestrol
Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations
Pharmacy, Oncology, Toxicology +17
Potential anticancer activity of turmeric (Curcuma longa)
Ramadasan Kuttan, P Bhanumathy, K. Nirmala et al. · Cancer Letters · 1985 · 682 citations
Medicine, Oncology, Pharmacology +13
Bharat B. Aggarwal, Shishir Shishodia, Yasunari Takada et al. · Clinical Cancer Research · 2005 · 580 citations
Medicine, Oncology, Pharmacology +14